True Private Wealth Advisors Vertex Pharmaceuticals Inc Transaction History

True Private Wealth Advisors

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 12, 2021	SELL	$207.02 - $241.31 $3,519 - $4,102	-17 Closed	0 $0
Q2 2020 Jul 07, 2020	BUY	$225.48 - $295.8 $3,833 - $5,028	17 New	17 $4,000
Q1 2020 Apr 20, 2020	SELL	$199.77 - $247.81 $170,204 - $211,134	-852 Closed	0 $0
Q4 2019 Jan 27, 2020	BUY	$166.71 - $223.91 $142,036 - $190,771	852 New	852 $186,000
Q3 2019 Oct 09, 2019	SELL	$166.23 - $187.09 $141,627 - $159,400	-852 Closed	0 $0
Q2 2019 Aug 01, 2019	BUY	$164.61 - $190.37 $140,247 - $162,195	852 New	852 $156,000
Q4 2018 Jan 14, 2019	SELL	$151.91 - $192.21 $133,073 - $168,375	-876 Closed	0 $0
Q3 2018 Oct 18, 2018	BUY	$167.73 - $192.74 $146,931 - $168,840	876 New	876 $0

1,725

221M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $105B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of True Private Wealth Advisors, based on Form 13F filings with the SEC.

Stay updated on True Private Wealth Advisors with notifications on news.